Achieve Life Sciences Stock Price, News & Analysis (NASDAQ:ACHV) $5.79 +0.07 (+1.22%) (As of 11/30/2023 ET) Add Compare Share Share Today's Range$5.70▼$5.8750-Day Range$3.65▼$5.8652-Week Range$2.36▼$10.30Volume9,395 shsAverage Volume101,069 shsMarket Capitalization$122.57 millionP/E RatioN/ADividend YieldN/APrice Target$18.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Achieve Life Sciences MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside222.4% Upside$18.67 Price TargetShort InterestBearish3.24% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.27Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.57) to ($1.41) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.88 out of 5 starsMedical Sector719th out of 949 stocksDiagnostic Substances Industry9th out of 13 stocks 3.5 Analyst's Opinion Consensus RatingAchieve Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.67, Achieve Life Sciences has a forecasted upside of 222.4% from its current price of $5.79.Amount of Analyst CoverageAchieve Life Sciences has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.24% of the outstanding shares of Achieve Life Sciences have been sold short.Short Interest Ratio / Days to CoverAchieve Life Sciences has a short interest ratio ("days to cover") of 16.7, which indicates bearish sentiment.Change versus previous monthShort interest in Achieve Life Sciences has recently decreased by 1.39%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAchieve Life Sciences does not currently pay a dividend.Dividend GrowthAchieve Life Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ACHV. Previous Next 2.4 News and Social Media Coverage News SentimentAchieve Life Sciences has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Achieve Life Sciences this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for ACHV on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Achieve Life Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of Achieve Life Sciences is held by insiders.Percentage Held by Institutions43.65% of the stock of Achieve Life Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Achieve Life Sciences are expected to grow in the coming year, from ($1.57) to ($1.41) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Achieve Life Sciences is -2.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Achieve Life Sciences is -2.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAchieve Life Sciences has a P/B Ratio of 30.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Achieve Life Sciences Stock (NASDAQ:ACHV)Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.Read More ACHV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ACHV Stock News HeadlinesNovember 29, 2023 | americanbankingnews.comAchieve Life Sciences (NASDAQ:ACHV) Share Price Passes Above 200-Day Moving Average of $5.15November 12, 2023 | markets.businessinsider.comPotential Growth and Success: Jason McCarthy’s Buy Recommendation for Achieve Life Sciences Amid Promising Cytisinicline ProgressNovember 30, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!November 11, 2023 | finance.yahoo.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: DENTSPLY SIRONA (XRAY), GoodRx Holdings (GDRX) and Achieve Life Sciences (ACHV)November 10, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Vor Biopharma (VOR), Gilead Sciences (GILD) and Achieve Life Sciences (ACHV)November 10, 2023 | finance.yahoo.comACHV: Ancillary Studies CompleteNovember 10, 2023 | finance.yahoo.comQ3 2023 Achieve Life Sciences Inc Earnings CallNovember 30, 2023 | Tomorrow Investor (Ad)Why Microsoft Just Placed A Huge Bet On NuclearEven with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.November 9, 2023 | finance.yahoo.comAchieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate UpdateNovember 2, 2023 | msn.comAchieve Credit Union surprises teacher at Horizon Science Academy of Lorain with gift cardNovember 2, 2023 | markets.businessinsider.comAchieve announces close of $157.5 million, AAA-rated personal loan securitizationOctober 30, 2023 | markets.businessinsider.comAchieve invests in top talent with appointment of Chief Operating Officer and Chief Security OfficerOctober 26, 2023 | finance.yahoo.comAchieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023October 23, 2023 | msn.comCollege Achieve Public Schools Named Semifinalist for $1M Education Innovation PrizeOctober 19, 2023 | msn.comTogether We Achieve gears up for winter with community coat driveSeptember 28, 2023 | nj.comCollege Achieve Central beats Roselle Park to extend win streak - Boys soccer recapSeptember 27, 2023 | nj.comCollege Achieve Central beats Rutgers Prep to extend win streak - Boys soccer recapSeptember 26, 2023 | msn.comCollege Achieve Public Schools Named Finalist for 2023 Yass Prize, Aiming to Transform EducationSeptember 22, 2023 | nj.comGirls soccer recap: Gabriela Garcia scores twice as College Achieve tops Lincoln LeadershipSeptember 22, 2023 | nj.comCollege Achieve Central defeats Delaware Valley - Boys soccer recapSeptember 20, 2023 | villagegreennj.comThe Achieve Foundation Newstead 5K is Saturday, September 30September 19, 2023 | usnews.comXi Says China, US 'Should and Must' Achieve Peaceful Co-ExistenceSeptember 15, 2023 | nj.comSummit shuts out College Achieve Central - Boys soccer recapSeptember 1, 2023 | msn.comExit Realty Achieve: Making Realty A Supportive, Collaborative BusinessAugust 16, 2023 | finance.yahoo.comACHV: 2Q:23 ResultsAugust 16, 2023 | finance.yahoo.comQ2 2023 Achieve Life Sciences Inc Earnings CallSee More Headlines Receive ACHV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/16/2023Today11/30/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/21/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryBiotechnology SectorMedical Current SymbolNASDAQ:ACHV CUSIP68230A10 CIK949858 Webachievelifesciences.com Phone(604) 210-2217Fax425-686-1600Employees20Year FoundedN/APrice Target and Rating Average Stock Price Target$18.67 High Stock Price Target$20.00 Low Stock Price Target$17.00 Potential Upside/Downside+222.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,350,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-632.85% Return on Assets-136.78% Debt Debt-to-Equity Ratio4.02 Current Ratio5.36 Quick Ratio5.36 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.19 per share Price / Book30.47Miscellaneous Outstanding Shares21,170,000Free Float20,743,000Market Cap$122.57 million OptionableNot Optionable Beta1.44 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Richard A. B. Stewart (Age 64)Executive Chairman Comp: $575kMr. John A. Bencich M.B.A. (Age 46)CEO & Director Comp: $733.12kDr. Cindy Jacobs M.D. (Age 65)Ph.D., President, Chief Medical Officer & Director Comp: $614.25kMr. Jerry Wan (Age 41)Principal Accounting Officer Dr. Anthony Clarke (Age 67)Chief Scientific Officer Comp: $546kMs. Jaime XinosExecutive Vice President of CommercialMore ExecutivesKey CompetitorsVolitionRxNYSE:VNRXAlpha TeknovaNASDAQ:TKNOCardio DiagnosticsNASDAQ:CDIOImmuCellNASDAQ:ICCCOncoCyteNASDAQ:OCXView All CompetitorsInsiders & InstitutionsLPL Financial LLCBought 16,500 shares on 11/13/2023Ownership: 0.779%Northern Trust CorpBought 5,379 shares on 11/13/2023Ownership: 0.374%Group One Trading L.P.Sold 12,300 shares on 11/9/2023Ownership: 0.000%Manchester Financial Inc.Bought 5,675 shares on 11/6/2023Ownership: 0.088%Belvedere Trading LLCSold 2,100 shares on 10/27/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions ACHV Stock Analysis - Frequently Asked Questions Should I buy or sell Achieve Life Sciences stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ACHV shares. View ACHV analyst ratings or view top-rated stocks. What is Achieve Life Sciences' stock price target for 2024? 2 analysts have issued 12-month price objectives for Achieve Life Sciences' stock. Their ACHV share price targets range from $17.00 to $20.00. On average, they predict the company's share price to reach $18.67 in the next twelve months. This suggests a possible upside of 222.4% from the stock's current price. View analysts price targets for ACHV or view top-rated stocks among Wall Street analysts. How have ACHV shares performed in 2023? Achieve Life Sciences' stock was trading at $2.45 at the beginning of 2023. Since then, ACHV shares have increased by 136.3% and is now trading at $5.79. View the best growth stocks for 2023 here. When is Achieve Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024. View our ACHV earnings forecast. How were Achieve Life Sciences' earnings last quarter? Achieve Life Sciences, Inc. (NASDAQ:ACHV) issued its quarterly earnings results on Thursday, March, 16th. The biopharmaceutical company reported ($0.83) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.07. During the same period in the previous year, the business earned ($0.76) EPS. When did Achieve Life Sciences' stock split? Achieve Life Sciences's stock reverse split on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Achieve Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI). Who are Achieve Life Sciences' major shareholders? Achieve Life Sciences' stock is owned by a number of retail and institutional investors. Top institutional investors include LPL Financial LLC (0.78%), Raymond James & Associates (0.69%), Northern Trust Corp (0.37%), Manchester Financial Inc. (0.09%), Group One Trading L.P. (0.00%) and Belvedere Trading LLC (0.00%). View institutional ownership trends. How do I buy shares of Achieve Life Sciences? Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:ACHV) was last updated on 11/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.